Neither earlier nor late tocilizumab improved outcomes in the intensive care unit patients with COVID-19 in a retrospective cohort study

Ann Rheum Dis. 2023 Jan;82(1):e3. doi: 10.1136/annrheumdis-2020-219265. Epub 2020 Oct 30.
No abstract available

Keywords: antirheumatic agents; autoimmunity; inflammation.

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19 Drug Treatment
  • COVID-19*
  • Humans
  • Intensive Care Units
  • Retrospective Studies

Substances

  • tocilizumab